Immunotherapy Against Head and Neck Cancer Stem Cells

被引:0
|
作者
Coordes, Annekatrin [1 ]
Ochsenreither, Sebastian [2 ,3 ]
Qian, Xu [1 ]
Hofmann, Veit Maria [1 ]
Meyer, Jens E. [4 ]
Hoffmann, Thomas Karl [5 ]
Kaufmann, Andreas M. [6 ]
Albers, Andreas E. [1 ]
机构
[1] Charite Univ Med Berlin, Klin Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Campus Benjamin Franklin,Hindenburgdamm 30, D-12200 Berlin, Germany
[2] Charite Univ Med Berlin, Klin Hamatol Onkol & Tumorimmunol, Campus Benjamin Franklin, Berlin, Germany
[3] Charite Univ Med Berlin, Charite Comprehens Canc Ctr, Berlin, Germany
[4] AK St Georg Hamburg, Abt Hals Nasen Ohrenheilkunde Kopf & Halschirurg, Hamburg, Germany
[5] Univ Ulm, Kopf & Hals Chirurg, Ohrenklin, Hals,Nasen, Ulm, Germany
[6] Charite Univ Med Berlin, Gynakol, Gynakol Tumorimmunol, Berlin, Germany
关键词
squamous cell cancer of the head and neck; epithelial-mesenchymal transition; cancer stem cell; human papilloma virus; immunotherapy; PD-L1; TO-MESENCHYMAL TRANSITION; INITIATING CELLS; HUMAN-PAPILLOMAVIRUS; PROSTATE-CANCER; SELF-RENEWAL; ANTITUMOR IMMUNITY; SQUAMOUS CARCINOMA; IN-VITRO; ANTIGEN; IDENTIFICATION;
D O I
10.1055/s-0043-101698
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Immunotherapy against head and neck cancer stem cells Immunologic therapies like antibodies in solid tumors like squamous cell cancer of the head and neck are administered either alone or in combination with radiation and chemotherapy. Despite some respectable successes, the effect of this therapy reaches its limits due the ability of the tumor to escape the immune system. Cancer stem cells seem to play an important role in this process due to their intrinsic resistance to conventional therapy and the ability to regenerate tumor heterogeneity. This way they substantially contribute to the formation of recurrences and metastases. Therefore, future immunotherapies should target specifically this subpopulation, possibly in combination with other therapeutic modalities. In this review the immunologic features of cancer stem cells and their potential as target for immunotherapies is summarized.
引用
收藏
页码:216 / 224
页数:9
相关论文
共 50 条
  • [21] Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
    Runnels, Juliana
    Bloom, Julie R.
    Hsieh, Kristin
    Dickstein, Daniel R.
    Shi, Yuhao
    Jones, Brianna M.
    Lehrer, Eric J.
    Bakst, Richard L.
    BIOMEDICINES, 2023, 11 (08)
  • [22] Immunotherapy for head and neck cancer: Present and future
    Fasano, Morena
    Della Corte, Carminia Maria
    Di Liello, Raimondo
    Viscardi, Giuseppe
    Sparano, Francesca
    Iacovino, Maria Lucia
    Paragliola, Fernando
    Piccolo, Antonio
    Napolitano, Stefania
    Martini, Giulia
    Morgillo, Floriana
    Cappabianca, Salvatore
    Ciardiello, Fortunato
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2022, 174
  • [23] Immunotherapy for head and neck cancer
    Davidson, H. Carter
    Leibowitz, Michael S.
    Lopez-Albaitero, Andres
    Ferris, Robert L.
    ORAL ONCOLOGY, 2009, 45 (09) : 747 - 751
  • [24] Immunotherapy of Head and Neck Cancer: Emerging Clinical Trials From a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting
    Bauman, Julie E.
    Cohen, Ezra
    Ferris, Robert L.
    Adelstein, David J.
    Brizel, David M.
    Ridge, John A.
    O'Sullivan, Brian
    Burtness, Barbara A.
    Butterfield, Lisa H.
    Carson, William E.
    Disis, Mary L.
    Fox, Bernard A.
    Gajewski, Thomas F.
    Gillison, Maura L.
    Hodge, James W.
    Quynh-Thu Le
    Raben, David
    Strome, Scott E.
    Lynn, Jean
    Malik, Shakun
    CANCER, 2017, 123 (07) : 1259 - 1271
  • [25] EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
    Kang, James J.
    Ko, Albert
    Kil, Sang Hoon
    Clair, Jon Mallen-St.
    Shin, Daniel Sanghoon
    Wang, Marilene B.
    Srivatsan, Eri S.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (01):
  • [26] Cancer stem cells in head and neck cancer
    Allegra, Eugenia
    Trapasso, Serena
    ONCOTARGETS AND THERAPY, 2012, 5 : 375 - 383
  • [27] Immunotherapeutics for head and neck squamous cell carcinoma stem cells
    Qian, X.
    Leonard, F.
    Wenhao, Y.
    Sudhoff, H.
    Hoffmann, T. K.
    Ferrone, S.
    Kaufmann, A. M.
    Albers, A. E.
    HNO, 2020, 68 (02) : 94 - 99
  • [28] Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Psyrri, Amanda
    CANCERS, 2020, 12 (11) : 1 - 23
  • [29] Immunotherapy for head and neck cancer patients: shifting the balance
    Turksma, Annelies W.
    Braakhuis, Boudewijn J. M.
    Bloemena, Elisabeth
    Meijer, Chris J. L. M.
    Leemans, C. Rene
    Hooijberg, Erik
    IMMUNOTHERAPY, 2013, 5 (01) : 49 - 61
  • [30] Heterogeneity of Head and Neck Squamous Cell Carcinoma Stem Cells
    Qian, Xu
    Nie, Xiaobo
    Wollenberg, Barbara
    Sudhoff, Holger
    Kaufmann, Andreas M.
    Albers, Andreas E.
    STEM CELLS HETEROGENEITY IN CANCER, 2019, 1139 : 23 - 40